Praxis Precision Medicines (PRAX)
(Delayed Data from NSDQ)
$40.54 USD
-3.29 (-7.51%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $40.49 -0.05 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Praxis Precision Medicines, Inc. [PRAX]
Reports for Purchase
Showing records 81 - 100 ( 101 total )
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Notes From the (Virtual) Road... Management Meetings Precede Busy 12+ Months
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
With PMD Data In Hand, Other Efforts Remain On Track
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Going Over The WATERFALL Results - We Still Think There''s A Path Forward
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
All Cylinders Firing In 1Q21 Report As Pipeline Expansion Continues
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
And Like That... It''s Gone. PRAX-114 Marches Towards Study Initiation
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Re-Visiting The Thesis - Putting The Pullback In Perspective
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Notes From The (Virtual) Road... Management Meetings Set Stage For A Busy 2021
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Looking Closer At The PRAX Pipeline: PRAX-562 Deep Dive, Raising Target to $61
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
CFO Transition Unexpected, But SAGE/BIIB Readthrough A Net Positive for PRAX
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L